ISRCTN61147621已完成不适用
CML IV - Chronic phase chronic myeloid leukaemia/CML 2000
Medical Research Council (MRC) (UK)0 个研究点目标入组 800 人开始时间: 2000年10月25日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 800
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. The interval from diagnosis to registration does not exceed 3 months (if received only hydroxyurea in these 3 months proceed to register, if alpha Interferon (IFN) has been given contact co-ordinators)
- •2. They are aged 18-60; they have newly diagnosed CML
- •3. They have acceptable criteria for chronic phase
- •4. They have given informed consent and are willing to be randomised, there is no contraindication to collection of blood or marrow progenitor cells before treatment is commenced
- •5. They are not pregnant
排除标准
- •Not provided at time of registration
研究者
相似试验
已完成
不适用
CML V - chronic phase Chronic Myeloid LeukaemiaeukaemiaMyeloid leukaemiaCancerISRCTN68784584niversity of Oxford (UK)800
已完成
不适用
The Observational Study of Chronic Myeloid Leukemia Patients in Chronic Phase with Resistance or Intolerance to Preceding TKI in JapaJPRN-UMIN000003582The Japanese Society of Hematology110
进行中（未招募）
1 期
Management of Transformed Chronic myeloid leukaemia: Ponatinib and Intensive chemotherapy: a dose-finding studyEUCTR2012-005629-65-GBniversity of Birmingham15
尚未招募
不适用
Chronic Myeloid LeukemiaCTRI/2021/08/035398DRREETIKA RAMANATHA
进行中（未招募）
不适用
Kroonista lymfaattista leukemiaa (KLL) sairastavien potilaiden pneumokokki-vasta-aineiden säilyvyys ja muistisolujen toiminta konjugaattirokotteen jälkeen. - KLLmuistiKroonista lymfaattista leukemiaa sairastavia potilaita ja heille immunologisesti terveitä verrokkejaMedDRA version: 1Level: LLTClassification code 10009310Term: <Manually entered code. Term in E.1.1>EUCTR2009-012099-29-FITampere University Hospital